Find a lawyerOur capabilitiesYour careerFRAUD WARNING
Locations
Our capabilities
News

Select language:

Locations
Our capabilities
News

Select language:

hamburger menu showcase image
New York

Arjun Karthikeyan

Counsel
arjun.karthikeyan@freshfields.com
New York: +1 212 277 4000
hero-banner-image

About

Arjun is counsel in our corporate/M&A practice, based in New York. He advises public and private companies on a broad range of U.S. and cross-border transactions, including mergers and acquisitions. He also advises clients on shareholder activism and engagement, corporate governance and general corporate matters.

Capabilities

Mergers and acquisitions
Corporate advisory and governance

Connect

Email

VCARD

Download
Additional Information

  • Integral Ad Science (Nasdaq: IAS) on its $1.9bn sale to Novacap
  • E2open Parent Holdings, Inc. (NYSE: ETWO) on its $2.1bn sale to WiseTech Global Limited (ASX: WTC)
  • Scorpion Therapeutics on its $2.5bn sale of the PI3Kα inhibitor program, a treatment for breast cancers in clinical trials, to Eli Lilly and Company (NYSE: LLY)
  • Haynes International on its sale to North American Stainless for approximately $1bn
  • Vince McMahon, founded and controlling stockholder of World Wrestling Entertainment, Inc. (WWE), on its:
    • $21bn+ merger of WWE and UFC to form a global live sports and entertainment company, TKO Group Holdings
    • actions in support of a plan for WWE to undertake a review of strategic alternatives, including the election of Mr. McMahon and two others to the WWE board
  • Disney (NYSE: DIS) in connection with:
    • ESPN’s strategic partnership with the XFL
    • the combination of the XFL and the USFL to form the United Football League (UFL)
  • Express, Inc. on its:
    • strategic partnership with global brand management firm, WHP Global
    • agreement with WHP Global to acquire Bonobos, Inc. from Walmart
  • Paya Holdings Inc. on its sale to Nuvei Corporation for approximately $1.3bn
  • Bristol Myers Squibb (NYSE: BMY) on its $4.1bn acquisition of Turning Point Therapeutics
  • FinServ Acquisition Corp. on its $1bn combination with Katapult Holding, Inc
  • Montes Archimedes Acquisition Corp. on its $7.3bn business combination with Roivant Sciences
  • Atlas Crest Investment Corp on its $1.7bn combination with Archer Aviation
  • The Special Committee of Board of Directors of Verso Corporation in response to an unsolicited takeover bid and subsequent $825m sale to BillerudKorsnäs
  • TPG Rise Climate on its investment in Elevated Materials, a joint venture with Applied Materials (Nasdaq: AMAT) to produce ultra-thin lithium films for next generation batteries
  • Copenhagen Infrastructure Partners on the sale of a minority interest in Soo Green HVDC Link HoldCo LLC, developer of an approximately 349-mile, 525-kilovolt underground transmission line connecting the PJM and MISO regions, to energyRe
  • Apax Partners on its acquisition of Infogain
  • Cerberus Capital Management on its acquisition of Source Code Holdings
  • The Special Committee of a construction equipment rental company in connection with c-suite and board investigations and related governance matters
  • An infrastructure fund in connection with its sale of wind-powered generation facilities in Texas

Shareholder Defense Matters

  • Victoria’s Secret & Co. (NYSE: VSXY) on its successful defense of “Vote No” proxy fight by BBRC International Pte Limited and its chairman Brett Blundy.
  • Southwest Airlines (NYSE: LUV) in resolving Elliott Management’s threatened special meeting proxy contest seeking to replace its CEO and a majority of the board
  • Constellation Brands (NYSE: STZ) in connection with cooperation and information sharing agreements with Elliott Management
  • Sylvamo (NYSE: SLVM) in connection with its cooperation agreement with Atlas Holdings
  • Huntsman Corporation (NYSE: HUN) on its successful defense of a proxy contest by Starboard Value

Shareholder Activism Matters

  • Alta Fox on its letter agreement with Collectors Universe for board representation and strategy initiative
  • Hestia Capital and Permit Capital on their proxy fight victory at GameStop Corp. to appoint two directors to the board
  • Ancora Advisors and Macellum Advisors on their cooperation agreement with Big Lots
  • Legion Partners, Ancora Advisors and Macellum Advisors on their cooperation agreement with Bed Bath & Beyond
  • Altiva Management on its consent solicitation victory at Progenics Pharmaceuticals Inc
  • Legion Partners on its cooperation and support agreement with Landec Corporation for board representation
  • Legion Partners on its cooperation agreement with NN, Inc. for board representation

Arjun Karthikeyan

Counsel
arjun.karthikeyan@freshfields.com

T +1 212 277 4000

New York Office

3 World Trade Center

175 Greenwich Street, 51st Floor

New York, NY 10007

NAVIGATE TO
About usLocations and officesYour careerOur thinkingOur capabilitiesNews
CONNECT
Find a lawyerAlumniContact us
NEED HELP
Fraud and scamsComplaintsTerms and conditions
LEGAL
AccessibilityCookiesLegal noticesTransparency in supply chains statementResponsible procurementPrivacy

Select language:
Select language:
© 2026 Freshfields. Attorney Advertising: prior results do not guarantee a similar outcome